Absorption Models to Examine Bioavailability and Drug-Drug Interactions in Humans

被引:0
|
作者
Rizwan, Ahsan Naqi [1 ]
Brouwer, Kim L. R. [1 ]
机构
[1] Univ N Carolina, Eschelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA
关键词
DIFFERENT REGIONS; IN-VITRO; JEJUNAL PERMEABILITY; BILIARY-EXCRETION; SMALL-INTESTINE; GI TRACT; PERFUSION; METABOLISM; PHARMACOKINETICS; EXPERIENCE;
D O I
10.1007/978-1-4419-0840-7_14
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human drug absorption studies are warranted in many situations. The development of modified release formulations, the evaluation of different formulations designed to improve bioavailability by enhancing solubility or permeability, the investigation of mechanisms of drug-drug/food interactions in the gastrointestinal tract, and the determination of intestinal and biliary secretion in humans all require assessment of drug absorption/excretion in the human gastrointestinal tract. This chapter discusses in vivo approaches that can be used to assess absorption/bioavailability issues in the human gastrointestinal tract. The design and the application of remotely activated capsules and aspiration/perfusion catheters are reviewed, and the utility of human microdose studies is discussed. With the use of appropriate probes, these approaches also may be used to assess drug drug or drug food interactions, as well as interactions involving transporters and enzymes present in the gastrointestinal tract and/or the liver.
引用
收藏
页码:343 / 370
页数:28
相关论文
共 50 条
  • [41] Recent development of machine learning models for the prediction of drug-drug interactions
    Eujin Hong
    Junhyeok Jeon
    Hyun Uk Kim
    [J]. Korean Journal of Chemical Engineering, 2023, 40 : 276 - 285
  • [42] Drug-drug interactions: An evolving science in need of experimental models and systems
    Blomme, Eric A.
    [J]. VETERINARY JOURNAL, 2014, 201 (01): : 1 - 2
  • [43] Comparison of metabolism and transporter models for predicting gemfibrozil drug-drug interactions
    Gibbons, Laura K.
    Galetin, Aleksandra
    Houston, J. Brian
    [J]. DRUG METABOLISM REVIEWS, 2006, 38 : 77 - 78
  • [44] Use of In Vivo Animal Models to Assess Pharmacokinetic Drug-Drug Interactions
    Cuyue Tang
    Thomayant Prueksaritanont
    [J]. Pharmaceutical Research, 2010, 27 : 1772 - 1787
  • [45] Use of In Vivo Animal Models to Assess Pharmacokinetic Drug-Drug Interactions
    Tang, Cuyue
    Prueksaritanont, Thomayant
    [J]. PHARMACEUTICAL RESEARCH, 2010, 27 (09) : 1772 - 1787
  • [46] DRUG-DRUG INTERACTIONS AS AN ISSUE IN DRUG DEVELOPMENT
    Jochemsen, R.
    Bouzom, F.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 2 - 2
  • [47] Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions
    Choi, Min-Koo
    Song, Im-Sook
    [J]. PHARMACEUTICS, 2021, 13 (05)
  • [48] DRUG UTILIZATION AND POTENTIAL DRUG-DRUG INTERACTIONS
    LAVENTURIER, MF
    TALLEY, RB
    HEFNER, DL
    KENNARD, LH
    [J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1976, 16 (02): : 77 - 81
  • [49] Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    Fokter, Nina
    Mozina, Martin
    Brvar, Miran
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (3-4) : 81 - 88
  • [50] The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions
    Kovacsics, Daniella
    Patik, Izabel
    Ozvegy-Laczka, Csilla
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (04) : 409 - 424